image

The best stocks to buy since 1993

Latest issue now available

Marlowe - Another from the Michael Ashcroft stable

June 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MRL
  • Price:
  • 178.5p
Marlowe (MRL; 178.5p) is yet another product of the shell revitalisation skills of Michael Ashcroft and all but one of its directors come from a stable of Ashcroft companies – chief executive is Alex Dacre, who headed up Impellam’s business development activities and was also at Restore. The finance director and interim chairman, Derek O’Neill, also comes from Impellam. Charles Skinner is a non executive and is also chief executive of Restore.The trio acquired a stake in a defunct cash shell aptly called Shellshock in April 2015, which had been listed since 2007. At the time Marlowe’s sole asset was cash of £3.1m but there was a subsequent placing in September at which point a further £5.2m was r ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe